RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)

CUSIP: 75629V104

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Class A Stock
Shares outstanding
525,302,736
Total 13F shares
94,346,907
Share change
+18,361,677
Total reported value
$1,616,473,942
Put/Call ratio
63%
Price per share
$17.13
Number of holders
122
Value change
+$295,962,917
Number of buys
94
Number of sells
19

Security key

75629V104

Report period

Q4 2021

Institutions

122

Top holders

10

Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VIKING GLOBAL INVESTORS LP
13F
Company
65%
339,055,144
$3,929,649,000 30 Sep 2021
13F
GENERAL ATLANTIC, L.P.
13F
Company
22%
114,886,852
$1,331,539,000 30 Sep 2021
13F
Senator Investment Group LP
13F
Company
15%
78,703,273
$912,171,000 30 Sep 2021
13F
Anchorage Capital Group, L.L.C.
13F
Company
13%
67,151,368
$778,284,000 30 Sep 2021
13F
FRANKLIN RESOURCES INC
13F
Company
1.7%
8,550,100
$99,095,000 30 Sep 2021
13F
Telemark Asset Management, LLC
13F
Company
1.2%
6,000,000
$69,540,000 30 Sep 2021
13F
Laurion Capital Management LP
13F
Company
0.75%
3,923,713
$90,285,000 30 Sep 2021
13F
Bain Capital Public Equity Management II, LLC
13F
Company
0.59%
3,039,000
$35,222,000 30 Sep 2021
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.58%
3,000,000
$34,770,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
0.52%
2,711,980
$62,403,000 30 Sep 2021
13F
Neuberger Berman Group LLC
13F
Company
0.51%
2,617,826
$30,340,000 30 Sep 2021
13F
TIGER GLOBAL MANAGEMENT LLC
13F
Company
0.47%
2,425,000
$28,106,000 30 Sep 2021
13F
Nicholas Investment Partners, LP
13F
Company
0.46%
2,381,270
$27,599,000 30 Sep 2021
13F
Chescapmanager LLC
13F
Company
0.39%
2,000,000
$23,180,000 30 Sep 2021
13F
FMR LLC
13F
Company
0.37%
1,959,963
$45,099,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
0.34%
1,767,659
$40,673,000 30 Sep 2021
13F
Blue Water Life Science Advisors, LP
13F
Company
0.33%
1,729,791
$17,643,000 30 Sep 2021
13F
PUTNAM INVESTMENTS LLC
13F
Company
0.32%
1,646,853
$19,087,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
0.31%
1,644,494
$37,840,000 30 Sep 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.31%
1,639,341
$37,721,000 30 Sep 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.29%
1,511,459
$17,518,000 30 Sep 2021
13F
SPRUCE HOUSE INVESTMENT MANAGEMENT LLC
13F
Company
0.29%
1,500,000
$17,385,000 30 Sep 2021
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.29%
1,509,254
$34,728,000 30 Sep 2021
13F
CREDIT SUISSE AG/
13F
Company
0.28%
1,450,596
$33,379,000 30 Sep 2021
13F
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC
13F
Company
0.26%
1,388,889
$31,958,000 30 Sep 2021
13F
Trybe Capital Management LP
13F
Company
0.23%
1,207,992
$14,001,000 30 Sep 2021
13F
Comprehensive Financial Management LLC
13F
Company
0.21%
1,109,395
$25,527,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.2%
1,042,313
$11,993,000 30 Sep 2021
13F
Kamunting Street Capital Management, L.P.
13F
Company
0.19%
998,664
$11,575,000 30 Sep 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.17%
894,188
$10,364,000 30 Sep 2021
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.17%
895,860
$20,614,000 30 Sep 2021
13F
Stockbridge Partners LLC
13F
Company
0.15%
800,000
$9,272,000 30 Sep 2021
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.14%
750,000
$8,693,000 30 Sep 2021
13F
Samsara BioCapital, LLC
13F
Company
0.14%
752,939
$17,325,000 30 Sep 2021
13F
CRV, LLC
13F
Company
0.14%
733,986
$16,889,000 30 Sep 2021
13F
BAMCO INC /NY/
13F
Company
0.13%
695,800
$16,010,000 30 Sep 2021
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.13%
661,703
$15,226,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.11%
562,331
$12,939,000 30 Sep 2021
13F
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
0.1%
548,455
$12,620,000 30 Sep 2021
13F
HIGHLINE CAPITAL MANAGEMENT, L.P.
13F
Company
0.1%
500,000
$5,795,000 30 Sep 2021
13F
NORGES BANK
13F
Company
0.1%
500,000
$11,505,000 30 Sep 2021
13F
Diameter Capital Partners LP
13F
Company
0.09%
487,253
$5,647,000 30 Sep 2021
13F
PointState Capital LP
13F
Company
0.08%
409,567
$9,424,000 30 Sep 2021
13F
Areion Asset Management Co Ltd
13F
Company
0.07%
379,644
$4,400,000 30 Sep 2021
13F
Yong Rong (HK) Asset Management Ltd
13F
Company
0.07%
377,000
$8,675,000 30 Sep 2021
13F
Gladstone Institutional Advisory LLC
13F
Company
0.06%
294,749
$3,416,000 30 Sep 2021
13F
Pentwater Capital Management LP
13F
Company
0.05%
265,000
$6,098,000 30 Sep 2021
13F
Duquesne Family Office LLC
13F
Company
0.05%
259,941
$5,981,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
0.05%
250,671
$5,768,000 30 Sep 2021
13F
HRT FINANCIAL LP
13F
Company
0.05%
233,238
$2,703,000 30 Sep 2021
13F

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q4 2021

As of 31 Dec 2021, RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 94,346,907 shares. The largest 10 holders included BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, Obvious Management Services, L.L.C., Data Collective IV GP, LLC, STATE STREET CORP, DCVC Opportunity Fund II GP, LLC, Laurion Capital Management LP, ALLIANCEBERNSTEIN L.P., and ARK Investment Management LLC. This page lists 122 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
82
Q4 2021 holders
122
Holder diff
40
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .